OptimizeRx Corporation OPRX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -703.00K | -495.00K | 5.02M | 779.00K | 1.53M |
| Total Depreciation and Amortization | 1.06M | 1.06M | 1.32M | 1.00M | 1.07M |
| Total Amortization of Deferred Charges | 277.00K | 358.00K | 81.00K | 254.00K | 437.00K |
| Total Other Non-Cash Items | 2.21M | 1.83M | 2.33M | 1.96M | 1.49M |
| Change in Net Operating Assets | 5.77M | -3.22M | -1.66M | -788.00K | 30.00K |
| Cash from Operations | 8.61M | -467.00K | 7.09M | 3.20M | 4.56M |
| Capital Expenditure | -35.00K | -21.00K | -11.00K | -10.00K | -10.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 217.00K | 0.00 | -34.00K |
| Cash from Investing | -35.00K | -21.00K | 206.00K | -10.00K | -44.00K |
| Total Debt Issued | 24.30M | -- | -- | -- | -- |
| Total Debt Repaid | -28.91M | -2.69M | -2.50M | -500.00K | -4.50M |
| Issuance of Common Stock | -- | -- | 14.00K | 338.00K | -- |
| Repurchase of Common Stock | -46.00K | -17.00K | -962.00K | -96.00K | -5.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -4.66M | -2.71M | -3.45M | -258.00K | -4.51M |
| Foreign Exchange rate Adjustments | 11.00K | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.93M | -3.20M | 3.85M | 2.93M | 12.00K |